The Interventional Orthobiologics Blog
Blog covering topics and research in interventional orthobiologics, interventional orthopedics, and orthopedic procedures.
The Latest ACL Regeneration Result
This will be a short blog this morning as I have to travel this morning. However, something that never gets old is seeing the amazing results of our Perc-ACLR procedure. Let’s dig into this morning’s example. What is Perc-ACLR? Perc-ACLR means “Percutaneous ACL Repair”. This is a procedure where we precisely inject a high dose…read more
What Is Failed Back Syndrome?
I see lots of patients with failed back syndrome. What’s that? Why does it happen? How can it be treated? Let’s dig in. What Is Failed Back Syndrome? Back surgery is unique in medicine in that many people know someone who has had it, and it either didn’t work or they got worse. When that…read more
A Lateral Collateral Ligament Tear: Listen To The Patient
I often write about what I experience in the clinic. Today I’d like to tell you about a patient who has a specific injury to his lateral collateral ligament but instead was told he needed the wrong surgery. How did that happen? The surgeon paid attention to the bright shiny object on the MRI. Let’s…read more
Bone Marrow Aspiration Is Where a Real Stem Cell Procedure Begins
I remember the concept from my medical training that a process is only as good as the weakest link. That’s how I feel about bone marrow aspiration. Most physicians do this part poorly, compromising the entire stem cell procedure. Let me explain. A Process and It’s Weakest Link A game-changing statement appeared in Thomas Reid’s…read more
BPA and Your Health, Stem Cells, and La Croix
I love drinking those creatively flavored and hipster loved “La Croix” waters. However, I have to say that a recent paper published in JAMA about the health effects of BPA freaked me out a bit, as I know those cans are lined with plastics. Let’s dig in. What is BPA? BPA stands for bisphenol-A. It’s…read more
Do Two FDA Warning Letters for Predictive Biotech Represent a Change in FDA Policy?
Predictive Biotech has made it onto the blog a few times, mostly for continuing to insist that it’s Wharton’s Jelly product is stem cell-rich. Hence, while other umbilical cord companies have received a steady barrage of letters from the FDA, I was wondering when Predictive would get their FDA communication. That just happened this week,…read more
